共 22 条
[1]
[Anonymous], 2011, BMJ BRIT MED J, DOI DOI 10.1136/BMJ.D2139
[2]
ENHANCEMENT BY FACTOR-V LEIDEN MUTATION OF RISK OF DEEP-VEIN THROMBOSIS ASSOCIATED WITH ORAL-CONTRACEPTIVES CONTAINING 3RD-GENERATION PROGESTAGEN
[J].
LANCET,
1995, 346 (8990)
:1593-1596
[4]
BOTTIGER LE, 1980, LANCET, V1, P1097
[6]
European Medicines Agency, 2013, BEN COMB HORM CONTR
[7]
FARLEY TMM, 1995, LANCET, V346, P1582
[8]
Furu K., 2008, Norsk Epidemiologi, V18, P129
[9]
Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis
[J].
BMJ-BRITISH MEDICAL JOURNAL,
2000, 321 (7270)
:1190-1195
[10]
RISK OF IDIOPATHIC CARDIOVASCULAR DEATH AND NONFATAL VENOUS THROMBOEMBOLISM IN WOMEN USING ORAL-CONTRACEPTIVES WITH DIFFERING PROGESTAGEN COMPONENTS
[J].
LANCET,
1995, 346 (8990)
:1589-1593